BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 23327727)

  • 1. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.
    Llombart B; Serra-Guillén C; Monteagudo C; López Guerrero JA; Sanmartín O
    Semin Diagn Pathol; 2013 Feb; 30(1):13-28. PubMed ID: 23327727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular approach in the treatment of dermatofibrosarcoma protuberans].
    Fattoruso SI; Visca P; Lopez M
    Clin Ter; 2008; 159(5):361-7. PubMed ID: 18998038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatofibrosarcoma protuberans: recent clinical progress.
    McArthur G
    Ann Surg Oncol; 2007 Oct; 14(10):2876-86. PubMed ID: 17647063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
    DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
    Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.
    Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Serra C; Requena C; Poveda A; Vistós JL; Almenar S; Llombart-Bosch A; Guillén C
    Histopathology; 2009 Jun; 54(7):860-72. PubMed ID: 19635106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New molecular approaches in dermatofibrosarcoma protuberans].
    Kaya G
    Rev Med Suisse; 2009 Jul; 5(211):1519-24. PubMed ID: 19694363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
    Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
    Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatofibrosarcoma protuberans in children: an update on the diagnosis and treatment.
    Kornik RI; Muchard LK; Teng JM
    Pediatr Dermatol; 2012; 29(6):707-13. PubMed ID: 22780227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.
    Reimann JD; Fletcher CD
    Am J Surg Pathol; 2007 Sep; 31(9):1371-7. PubMed ID: 17721193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies.
    Thway K; Noujaim J; Jones RL; Fisher C
    Ann Diagn Pathol; 2016 Dec; 25():64-71. PubMed ID: 27806849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.
    McArthur GA; Demetri GD; van Oosterom A; Heinrich MC; Debiec-Rychter M; Corless CL; Nikolova Z; Dimitrijevic S; Fletcher JA
    J Clin Oncol; 2005 Feb; 23(4):866-73. PubMed ID: 15681532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
    Mentzel T; Schärer L; Kazakov DV; Michal M
    Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatofibrosarcoma protuberans: a review of the literature.
    Bogucki B; Neuhaus I; Hurst EA
    Dermatol Surg; 2012 Apr; 38(4):537-51. PubMed ID: 22288484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Realization of clinical diagnoses and treatment for dermatofibrosarcoma protuberans].
    Cai H; Shi YQ; Wang YN; Zhu HY; Mo SJ
    Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):678-82. PubMed ID: 15329259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in management of dermatofibrosarcoma protuberans.
    Johnson-Jahangir H; Ratner D
    Dermatol Clin; 2011 Apr; 29(2):191-200, viii. PubMed ID: 21421145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Morphea to Dermatofibrosarcoma Protuberans.
    Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatofibrosarcoma protuberans: a surgical disease with a molecular savior.
    McArthur GA
    Curr Opin Oncol; 2006 Jul; 18(4):341-6. PubMed ID: 16721128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of dermatofibrosarcoma protuberans.
    Lim SX; Ramaiya A; Levell NJ; Venables ZC
    Clin Exp Dermatol; 2023 Mar; 48(4):297-302. PubMed ID: 36630365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pigmented fibrosarcomatous dermatofibrosarcoma protuberans (Bednar tumor). 3 case reports, analogy with the "conventional" type and review of the literature].
    Bisceglia M; Vairo M; Calonje E; Fletcher CD
    Pathologica; 1997 Jun; 89(3):264-73. PubMed ID: 9380420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatofibrosarcoma Protuberans.
    Allen A; Ahn C; Sangüeza OP
    Dermatol Clin; 2019 Oct; 37(4):483-488. PubMed ID: 31466588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.